Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer.
A 40-year old patient with small cell lung cancer (SCLC) was treated with combined modalities including high-dose chemotherapy with subsequent autologous peripheral blood progenitor cell transplantation plus adjuvant radiotherapy. He achieved complete remission with regards to the primary disease. After an interval of 28 months, he was diagnosed with chronic myelogenous leukemia (CML). Analysis of graft samples at time of primary treatment for SCLC using polymerase chain reaction (PCR) did not show the bcr-abl transcript characteristic for CML. This case supports the observation that CML can develop as a treatment-related malignancy and gives insight in the length of the preclinical phase of the disease.
Waller
C F
CF
Department of Internal Medicine I--Hematology/Oncology, Albert-Ludwigs-University Freiburg Medical Center, Germany. waller@mm11.ukl.uni-freiburg.de
Fetscher
S
S
Lange
W
W
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology* / Q000503:physiopathology; D007953:Leukemia, Radiation-Induced / Q000209:etiology / Q000503:physiopathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy; D008297:Male; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000503:physiopathology